NHS to block ‘best ever’ Alzheimer’s drug due to high costs
- Posted on October 22, 2024
- By The Times
- 4 Views
NHS to block ‘best ever’ Alzheimer’s drug due to high costs
Despite approval in the US, the NHS will likely limit donanemab to clinical trials at private clinics
